DBV Technologies, a clinical-stage biopharmaceutical company, will hold its Ordinary and Extraordinary General Meeting on April 12, 2023, at 10:00 a.m. CET at the Company’s headquarters located at 177-181 Avenue Pierre Brossolette – 92120 Montrouge, France.
March 24, 2023
· 3 min read